Membrane type I matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators

Circulation

Volumn 99, Issue 24, 1999, Pages 3103-3109

  Rajavashisth, Tripathi B ^a,c   Xu, Xiao Ping ^a   Jovinge, Stefan ^a   Meisel, Simcha ^a   Xu, Xiao Ou ^a   Chai, Ning Ning ^a   Fishbein, Michael C ^b   Kaul, Sanjay ^a   Cercek, Bojan ^d   Sharifi, Behrooz ^a   Shah, Prediman K ^a,c  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NONE

Author keywords

Cells; Lipoproteins; Metalloproteinases; Proteins

Indexed keywords

GELATIN; GELATINASE A; INTERLEUKIN 1ALPHA; MATRIX METALLOPROTEINASE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; ENZYME PRECURSOR; GELATINASE; INTERLEUKIN 1; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METALLOPROTEINASE; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CATALYSIS; CELL STIMULATION; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE; MEDIATOR RELEASE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ZYMOGRAPHY; ARTERIOSCLEROSIS; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

ANTIBODIES, MONOCLONAL; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; CELLS, CULTURED; CORONARY VESSELS; ENZYME PRECURSORS; FLOW CYTOMETRY; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; LIPOPROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; RNA, MESSENGER; SAPHENOUS VEIN; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033594811     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.24.3103     Document Type: Article

References (32)

1. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
2. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Biol. 1995;7:728-735.
3. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions, association of active enzyme synthesis with unstable angina. Circulation. 1995;91: 2125-2131.
4. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
5. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT. Stetler-Stevenson WG, Froehlich J, Lakatta EG. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol. 1996;148:121-128.
6. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
7. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92:1393-1398.
8. Shah PK, Falk E, Badimon JJ, Levy G, Ortiz AF, Mailhac A, Levy GV, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived Mφ induce collagen breakdown in atherosclerotic fibrous caps: potential role of matrix degrading metalloproteinases and implication for plaque rupture. Circulation. 1995;92:1565-1569.
9. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
10. James TW, Wagner R, White LA, Zwolak RM. Brinckerhoff CE. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J Cell Physiol. 1993;157:426-437.
11. Southgate KM, Fisher M, Banning AP, Thurston VJ, Baker AH, Fabunami RP. Groves PH, Davies M, Newby AC. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res. 1996;79:1177-1187.
12. Jenkins GM, Crow MT. Bilato C, Gluzband Y. Ryu W-S, Li Z, Stetler-Stevenson W, Nater C, Froehlich JP, Lakatta EG, Cheng L. Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries. Circulation. 1998;97:82-90.
13. Strongin AY, Bannikov G, Manner BL, Grant GA, Goldberg GI. Mechanism of cell-surface activation of 72 kDa type IV gelatinase. J Biol Chem. 1995;270:5331-5338.
14. 3. Cell. 1996;85:683-693.
15. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature. 1994;370:61-65.
16. Shofuda K, Yasumitsu H, Nishihashi A, Miki K, Miyazaki K. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. J Biol Chem. 1997;272:9749-9754.
17. Loppnow H, Libby P. Functional significance of human vascular smooth muscle cells-derived interleukin 1 in paracrine and autoregulation pathways. Exp Cell Res. 1992;198:283-290.
18. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;44:254-257.
19. Peng HB, Rajavashisth TB, Libby, P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem. 1995;270:17050-17055.
20. Berliner JA, Territo MC, Sevanian A, Ramin J, Kim JA, Bombshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85: 1260-1266.
21. Chomzynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Liao JK, Homcy CJ. Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor. Circ Res. 1992;70:1018-1026.
23. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1988.
24. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
25. Jovinge S, Ares MP, Kallin B, Nilsson J. Human monocytes/Mφ release TNF-α in response to Ox-LDL. Arterioscler Thromb Vasc Biol. 1996;16: 1573-1579.
26. Weiss SJ, Pepper G, Ortiz X, Ragsdale C, Test ST. Oxidative activation of latent collagenase by human neutrophils. Science. 1985;227:747-749.
27. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J Clin Invest. 1996;98:2572-2579.
28. Strongin AY, Marmar BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem. 1993;268:14033-14039.
29. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases. Cancer Res. 1996;56:2707-2710.
30. d'Ortho MP, Stanton H, Butler M, Atkinson SJ, Murphy G, Hembry RM. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett. 1998;421:159-164.
31. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-285.
32. Kolodgie FD, Luna RE, Farb A, Burke AP, Horiba K, Ferrans VJ, Stetler-Stevenson WG, Virmani R. Differential expression of matrix metalloproteinases in coronary thrombosis: plaque rupture and erosion. J Am Coll Cardiol. 1998;31:419A. Abstract.